[1]Li X#, Zhang X#, Zhao S#, Pei S, Sun J, Dong L, Pan X, Wang W, Liu H, Huang Y, Liu T, Deng J, Hu C, Lv C, Su J, Chen X*,Yin M*. The dynamically evolving cell states and ecosystem from benign nevi to melanoma. Clin Cancer Res. 2025 Mar 17. doi: 10.1158/1078-0432.CCR-24-2971.（Q1, 10.4）
[2]Wang W#, Li X#*, Hu R, Dong L, Pei S, Jin L, Gao Q, Chen X*,Yin M*. BET inhibitor in combination with Bacillus Calmette-Guérin vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma. Cell Rep Med. 2025 Mar 18;6(3):101995.（Q1, 11.7）
[3]Dong L#, Hu S#, Li X, Pei S, Jin L, Zhang L, Chen X*, Min A*,Yin M*.SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis-Associated Tumor Cells by Remodeling the Lymph Node Microenvironment. Adv Sci (Weinh). 2024 Nov;11(44):e2400524. doi: 10.1002/advs.202400524.（Q1, 15.1）
[4]Pan X#, Li X#, Dong L#, Liu T, Zhang M, Zhang L, Zhang X, Huang L, Shi W, Sun H, Fang Z, Sun J,Huang Y, Shao H, Wang Y, Yin M*.Tumour vasculature at single-cell resolution. Nature. 2024 Aug;632(8024): 429-436.（Q1, 50.5）
[5]Chen M#, Shan H#, Tao Q, Hu R, Sun Q, Zheng M, Chen Z, Lin Q,Yin M*, Zhao S*, Chen X*, Chen Z*. Mimicking Tumor Metastasis Using a Transwell-Integrated Organoids-On-a-Chip Platform. Small. 2024Jul;20(27):e2308525. doi: 10.1002/smll.202308525.（Q1, 13.3）
[6]Hu R#, Hou H#, Li Y#, Zhang M, Li X, Chen Y, Guo Y, Sun H, Zhao S, Liao M, Cao D, Yan Q*, Chen X*,Yin M*. Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. Theranostics.2024Jan 1; 14(2):593-607. doi:10.7150/thno.85437.（Q1, 12.4）
[7]Fang Z#, Liu T#, Zheng R, A J,Yin M*, Li M*. stAA: adversarial graph autoencoder for spatial clustering task of spatially resolved transcriptomics. Brief Bioinform. 2023 Nov 22;25(1):bbad500. doi: 10.1093/bib/bbad500.(Q1, 13.994)
[8]DengJ#, PanT#, LvC, CaoL, LiL, ZhouX, LiG, LiH, VicencioJM, XuY, WeiF, WangY, LiuZ*, ZhouG*,YinM*.Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer.Theranostics.2023 Sep 11; 13(14): 5057-5074. doi:10.7150/thno.84937.（Q1，12.4）
[9]Liu T, Fang ZY, Li X, Zhang LN, Cao DS*,Yin MZ*. Graph deep learning enabled spatial domains identification for spatial transcriptomics. BriefBioinform. 2023May 19, 24(3):bbad146.doi: 10.1093/bib/bbad146.（Q1，13.994）
[10]Hu R, Li Y, Guo Y, Li X, Du S, Liao M, Hou H, Sun H, Zhao S, Su J, Chen X*,Yin M*. BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacol Res. 2023Jan, 187: 106609. doi: 10.1016/j.phrs.2022.106609.（Q1，10.334）
[11]Zeng F#, Li Y#, Meng Y, Sun H, He Y,Yin M*, Chen X*, Deng G*. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression. Exp Mol Med. 2023Feb, 55(2): 364-376. doi: 10.1038/s12276-023-00936-y.（Q1，12.8）
[12]Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Morrow JS, Pusztai L, Rimm DL,Yin M*, Yan Q*. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. SciTranslMed. 2022Feb 2, 14 (630): eabf5473. doi: 10.1126/scitranslmed.abf5473.（Q1,17.1）
[13]Deng G#, Zeng F#, He Y, Meng Y, Sun H, Su J, Zhao S, Cheng Y, Chen X*,Yin M*.EEF2K silencing inhibits tumour progression through repressing SPP1 and synergizes with BET inhibitors in melanoma. Clin Transl Med. 2022Feb, 12(2): e722. doi: 10.1002/ctm2.722.（Q1,10.6）
[14]Chen X, Wang K, Jiang S, Sun H, Che X, Zhang M, He J, Wen Y, Liao M, Li X, Zhou X, Song J, Ren X, Yi W, Yang J, Chen X,Yin M*, Cheng Y*. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. J Immunother Cancer. 2022Mar, 10(3): e004026. doi: 10.1136/jitc-2021-004026.（Q1, 10.9）
[15]Li X#, Zhao S#, Bian X#, Zhang L, Lu L, Pei S, Dong L, Shi W, Huang L, Zhang X, Chen M, Chen X*,Yin M*. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. Theranostics, 2022Oct 31, 12(17): 7532-7549. doi: 10.7150/thno.77528.（Q1，12.4）
[16]Yin M*, Guo Y, Hu R, Cai WL, Li Y, Pei S, Sun H, Peng C, Li J, Ye R, Yang Q, Wang N, Tao Y, Chen X*, Yan Q*. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nat Commun. 2020Apr 14, 11(1): 1833. doi: 10.1038/s41467-020-15290-0.（Q1，14.919）
[17]Deng G, Zeng F*, Zhang L*, Chen H*, Chen X*,Yin M*. Characteristics of Pregnant COVID-19 Patients with Liver Injury. J Hepatol. 2020Oct, 73(4): 989-991. doi: 10.1016/j.jhep.2020.06.022.（Q1，25.083）
[18]Li Z#,Yin M#, Zhang H, Ni W, Pierce RW, Zhou HJ, Min W. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis. Circ Res. 2020Feb 14, 126(4): 471-485. doi: 10.1161/CIRCRESAHA.119.315769.（Q1，17.367）
[19]Deng G#, Zeng F#, Su J, Zhao S, Hu R, Zhu W, Hu S, Chen X*,Yin M*. BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway. Theranostics. 2020Sep 15, 10(25): 11428-11443. doi: 10.7150/thno.47432.（Q1，11.556）
[20]Yin M#, Li X#, Tan S#, Zhou HJ, Ji W, Bellone S, Xu X, Zhang H, Santin AD, Lou G*, Min W*. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016Nov 1, 126(11): 4157-4173. doi: 10.1172/JCI87252.（Q1，12.784）
